LENZ Therapeutics, Inc. — All Filings
327 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001815776-24-000060 | Aug 14, 2024 | Jun 30, 2024 |
| 424B3 | 424B3 | 0001628280-24-037221 | Aug 14, 2024 | — |
| 8-K | 8-K | 0001815776-24-000053 | Aug 12, 2024 | — |
| 424B3 | 424B3 | 0001628280-24-036611 | Aug 12, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-083538 | Jul 29, 2024 | — |
| 4 | FORM 4 | 0001815776-24-000051 | Jul 23, 2024 | Jul 22, 2024 |
| 8-K | 8-K | 0001815776-24-000049 | Jul 15, 2024 | Jul 14, 2024 |
| 424B3 | 424B3 | 0001628280-24-031841 | Jul 15, 2024 | — |
| S-8 | S-8 | 0001628280-24-024451 | May 21, 2024 | — |
| 4 | FORM 4 | 0001815776-24-000046 | May 15, 2024 | May 14, 2024 |
| 4 | FORM 4 | 0001815776-24-000044 | May 14, 2024 | May 13, 2024 |
| 424B3 | 424B3 | 0001628280-24-022248 | May 9, 2024 | — |
| 10-Q | 10-Q | 0001815776-24-000042 | May 8, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0001815776-24-000039 | May 8, 2024 | — |
| 424B3 | 424B3 | 0001628280-24-015671 | Apr 11, 2024 | — |
| EFFECT | — | 9999999995-24-000927 | Apr 10, 2024 | — |
| S-1/A | S-1/A | 0001628280-24-015318 | Apr 9, 2024 | — |
| CORRESP | — | 0001628280-24-015319 | Apr 8, 2024 | — |
| SC 13G/A | — | 0000935836-24-000347 | Apr 8, 2024 | — |
| 8-K | 8-K | 0001815776-24-000035 | Apr 3, 2024 | — |
| UPLOAD | — | 0000000000-24-003611 | Apr 3, 2024 | — |
| S-1 | S-1 | 0001628280-24-013816 | Mar 29, 2024 | — |
| SC 13D | SC 13D | 0001104659-24-040539 | Mar 28, 2024 | — |
| SC 13G | LENZ THERAPEUTICS, INC. | 0000902664-24-002661 | Mar 28, 2024 | — |
| 3 | — | 0000902664-24-002662 | Mar 28, 2024 | Mar 21, 2024 |
| SC 13G/A | SC 13G/A | 0001104659-24-038578 | Mar 25, 2024 | — |
| 4 | FORM 4 | 0001815776-24-000029 | Mar 25, 2024 | Mar 21, 2024 |
| 3 | — | 0001415889-24-009075 | Mar 25, 2024 | Mar 21, 2024 |
| 4 | 4 | 0000950170-24-035951 | Mar 25, 2024 | Mar 21, 2024 |
| 3 | 3 | 0000950170-24-035939 | Mar 25, 2024 | Mar 21, 2024 |
| 3 | FORM 3 | 0001815776-24-000011 | Mar 25, 2024 | Mar 21, 2024 |
| SC 13G | LENZ THERAPEUTICS, INC. | 0000902664-24-002595 | Mar 25, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-24-076566 | Mar 25, 2024 | — |
| 3 | FORM 3 | 0001815776-24-000012 | Mar 25, 2024 | Mar 21, 2024 |
| 4 | FORM 4 | 0001815776-24-000027 | Mar 25, 2024 | Mar 21, 2024 |
| 3 | FORM 3 | 0001815776-24-000015 | Mar 25, 2024 | Mar 21, 2024 |
| 3 | FORM 3 | 0001815776-24-000016 | Mar 25, 2024 | Mar 21, 2024 |
| 3 | FORM 3 | 0001815776-24-000017 | Mar 25, 2024 | Mar 21, 2024 |
| 3 | FORM 3 | 0001815776-24-000018 | Mar 25, 2024 | Mar 21, 2024 |
| 3 | FORM 3 | 0001815776-24-000019 | Mar 25, 2024 | Mar 21, 2024 |
| 4 | FORM 4 | 0001815776-24-000020 | Mar 25, 2024 | Mar 21, 2024 |
| 3 | FORM 3 | 0001815776-24-000014 | Mar 25, 2024 | Mar 21, 2024 |
| 4 | FORM 4 | 0001815776-24-000021 | Mar 25, 2024 | Mar 21, 2024 |
| 4 | FORM 4 | 0001815776-24-000022 | Mar 25, 2024 | Mar 21, 2024 |
| 4 | FORM 4 | 0001815776-24-000023 | Mar 25, 2024 | Mar 21, 2024 |
| 4 | FORM 4 | 0001815776-24-000025 | Mar 25, 2024 | Mar 21, 2024 |
| 3 | — | 0001415889-24-009071 | Mar 25, 2024 | Mar 21, 2024 |
| 4 | FORM 4 | 0001815776-24-000026 | Mar 25, 2024 | Mar 21, 2024 |
| 4 | — | 0001415889-24-009073 | Mar 25, 2024 | Mar 21, 2024 |
| 4 | FORM 4 | 0001815776-24-000028 | Mar 25, 2024 | Mar 21, 2024 |